Affinity Biosensors
Pre-clinicalAffinity Biosensors’ LifeScale platform delivers rapid, high-throughput phenotypic antimicrobial susceptibility testing in under four hours, empowering clinical labs to make timely antibiotic decisions and combat drug-resistant infections.
Founded
2009
Focus
Diagnostics
About
Affinity Biosensors’ LifeScale platform delivers rapid, high-throughput phenotypic antimicrobial susceptibility testing in under four hours, empowering clinical labs to make timely antibiotic decisions and combat drug-resistant infections.
Funding History
5Total raised: $14.4M
Series A$8MAnzu PartnersAug 15, 2022
Seed$3.2MUndisclosedMay 15, 2019
Seed$2MUndisclosedApr 15, 2019
Grant$500KNational Science FoundationJun 15, 2017
Company Info
TypePrivate
Founded2009
LocationSanta Barbara, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile